Health is failing to cut through in the media coverage and on social platforms despite the country being in the midst of a pandemic.
Study led by Monash University scientists has found that a combination of phages and antibiotics may be far more effective against bacterial infections.
Australia’s biotechnology sector has united to launch a strategy for the Australian Biotechnology Industry
The innovative, non-invasive therapy utilises the radioisotope Rhenium-188 and is applied only to the area requiring treatment, sparing healthy tissue.
As demand for alternative protein sources grows, Australians are increasingly looking for options that are healthy, sustainable and ethically made.
Projects to develop an mRNA vaccine for bacterial infections and a device to treat heart failure share in more than $32 million in funding
Basic science is far more than the translatable research outcomes it might enable. It is also the catalyst for significant advances in our social and economic wellbeing.
Building on fundamental gene technologies, Australian scientists have adapted a treatment for children’s cancer into a tool to target and suppress the virus that causes COVID-19.
From fundamental cellular studies in the 1950s, synthetic biology will become a multi-billion-dollar opportunity in coming decades.
Australian designed, sustainable scrubs made from 48% recycled post-consumer water bottles.
Australia company Bionic Vision Technologies is in the race to produce the first bionic eye.
New imaging software can accurately diagnose jaundice in newborn babies and set treatment in action.
Register for the next ANSTO x Science Meets Business Innovation Series exploring how nuclear is medicine delivering improvements in human health and the treatment and diagnosis of cancer.
The two leading nuclear medicine enterprises have come together to develop, manufacture and supply radiopharmaceuticals for cancer treatments.
The Prime Minister’s Prizes for Science are Australia’s most prestigious awards for outstanding achievements in scientific research, research-based innovation, and excellence in science teaching.
Innovative microscope slide promises to revolutionise medical imaging.
Tower’s background in pharmacology and immunology landed her a place in the CSL Graduate Program, based at Seqirus, CSL’s vaccine-manufacturing business.
Scientists in universities across Australia, energised by the pitched battle against COVID-19, are developing a suite of home-made solutions to future scourges.
Newly engineered nanoparticles developed by scientists at the University of South Australia to treat drug-resistant fungal infections.
A ‘warm’ COVID-19 vaccine suitable for remote and resource-limited locations lacking access to cold storage supply chains is one step closer following an international collaboration between scientists from India and Australia.
Microba Life Sciences and Illumina partner to advance understanding of the human gut microbiome in human health and disease.
A new project using artificial intelligence technology could spell a medical breakthrough for people suffering from, or at risk of, coronary artery disease, the single leading cause of death in Australia.
A needle-free COVID-19 vaccination could be possible, with University of Queensland scientists successfully protecting mice from the virus by administering a US-developed vaccine candidate with a ‘patch’.